受注:045-509-1970 |
技術サポート:[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
|
化学式 | C24H23F3N4O |
|||
分子量 | 440.46 | CAS No. | 1807861-48-8 | |
Solubility (25°C)* | 体外 | DMSO | 88 mg/mL (199.79 mM) | |
Ethanol | 88 mg/mL (199.79 mM) | |||
Water | Insoluble | |||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
製品説明 | ONC212, a fluorinated-ONC201 analogue, is a selective agonist of GPR132. ONC212 is broadly efficacious across most solid tumors and hematological malignancies in the low nanomolar range and has robust anti-leukemic activity. |
---|---|
in vitro | ONC212 shows an anti-proliferative effect in a large panel of pancreatic cancer cell lines with ONC212 having at least a ten-fold increased potency than ONC201. ONC212 induces apoptosis earlier and at lower concentrations than ONC201 in sensitive pancreatic cancer cell lines[1]. ONC212 exerts potent and prominent apoptogenic effects on acute myeloid leukemia (AML) and mantle cell lymphoma (MCL) cell lines (e.g., ED50s of 141.0 nM in p53 wild-type OCI-AML3 cells, 105.7 nM in MOLM13 cells, and 265.2 nM in p53-null JeKo-1 cell lines). Time course analysis of apoptosis in OCI-AML3 cells shows that ONC212 takes more than 36 hours to start to induce apoptosis[2]. ONC212 significantly induces Sub-G1 apoptotic cells and/or cell cycle arrest[4]. |
in vivo | ONC212 shows improved efficacy in melanoma and hepatocellular carcinoma xenograft models[1]. ONC212 has a broad therapeutic window, an acceptable PK profile, and is orally well-tolerated in mice with no evidence of toxicity at efficacious doses in both colon and triple negative breast cancer[3]. ONC212 exhibits rapid kinetics of activity. ONC212 has a slightly shorter half-life than ONC201, with a clearance from the blood at 12 hours, T1/2 of 4.3 hours, and Cmax of 1.4 mg/mL. It has a prolonged pharmacodynamic effect despite systemic clearance. Oral ONC212 shows potent anti-tumor efficacy in a human melanoma xenograft and hepatocellular model. ONC206 and ONC201 both inhibit invasion and migration of tumor cells while ONC212 inhibits only invasion[4]. |
細胞アッセイ | 細胞株 | PANC-1 and HPAF-Ⅱ cells |
---|---|---|
濃度 | 5 µM or 20 µM | |
反応時間 | 72 h | |
実験の流れ | Colony formation assays are performed by seeding 0.2 × 106 cells/well in a 6-well plate and treatment with indicated doses of ONC201 or ONC212. At 72 hours post-treatment, cells are harvested and 500 cells per treatment group are plated in drug-free media in triplicate for colony formation. Colonies are stained with 0.25% crystal violet on Day 10, imaged, counted and reported as number of colonies ± SEM. |
|
動物実験 | 動物モデル | PANC-1, Capan-2, HPAF-II and BxPC3 xenograft models (athymic nu/nu mice) |
投薬量 | 50 mg/kg | |
投与方法 | by oral gavage |
Untersuchung zur Wirkung von tumortherapeutisch relevanten Imipridonderivaten auf den spannungsabhängigen Natriumkanal hNav1. 5 [ OPARU, 2023, 10.18725/OPARU-48122] | PubMed: none |
Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpP [ Pharmacol Res Perspect, 2022, 10(4):e00993] | PubMed: 35929764 |
Block of Voltage-Gated Sodium Channels as a Potential Novel Anti-cancer Mechanism of TIC10 [ Front Pharmacol, 2021, 12:737637] | PubMed: 34744721 |
Targeting Mitochondria in Melanoma [ Biomolecules, 2020, 10(10)E1395] | PubMed: 33007949 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。